Most high-risk neuroblastomas exhibit high levels of telomerase activity, which are caused by induction of the telomerase reverse transcriptase (TERT) gene through MYCN over-expression in MYCN-amplified tumors, or through genomic rearrangements of the TERT locus [5, 6]. This evidence concerns the gene MYCN and neuroblastoma.